Reporting owner · Q3 2026 · CIK 1073387

Bennett C Frank: insider trades.

Bennett C Frank reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.7M), across 1 company.

Transactions
4
Purchases (P)
0
Sales (S)
2
Companies
1
Name as filed
BENNETT C FRANK

Companies

CompanyRelationshipTransactions
Ionis Pharmaceuticals Inc (IONS)Officer · EVP, Chief Scientific Officer4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-31Ionis Pharmaceuticals IncJ110$51.3160,128Form 4
2026-07-07Ionis Pharmaceuticals IncS15,000$85.460Form 4
2026-07-07Ionis Pharmaceuticals IncS5,536$83.5875,018Form 4
2026-07-07Ionis Pharmaceuticals IncJ15,000$015,000Form 4

Questions

What stock did Bennett C Frank buy or sell?

Bennett C Frank reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($1.7M), across 1 company.

Is Bennett C Frank the same person as other filers with this name?

This page covers SEC CIK 1073387 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/bennett-c-frank-1073387.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.